ATRC - AtriCure, Inc.

QQQ $ 472.93 $ -0.50 (-0.11 %)

DIA $ 411.97 $ 2.70 (0.66 %)

SPY $ 560.27 $ 0.00 (0 %)

TLT $ 100.12 $ -0.47 (-0.47 %)

GLD $ 237.77 $ 0.18 (0.08 %)

Previous Close

$ 27.71

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 18.94 - $ 44.92

Volume

637,137

Average Volume

Market Cap

1.35B

Beta (5Y Monthly)

$ 1.37

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-16-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	07-26-2023	06-30-2023	10-Q
6	05-03-2023	03-31-2023	10-Q
7	02-22-2023	12-31-2022	10-K
8	11-02-2022	09-30-2022	10-Q
9	08-03-2022	06-30-2022	10-Q
10	05-04-2022	03-31-2022	10-Q
11	02-17-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	04-28-2021	03-31-2021	10-Q
15	02-26-2021	12-31-2020	10-K
16	11-06-2020	09-30-2020	10-Q
17	07-29-2020	06-30-2020	10-Q
18	04-30-2020	03-31-2020	10-Q
19	02-24-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	07-31-2019	06-30-2019	10-Q
22	04-26-2019	03-31-2019	10-Q
23	03-01-2019	12-31-2018	10-K
24	11-02-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	04-27-2018	03-31-2018	10-Q
27	02-28-2018	12-31-2017	10-K
28	11-02-2017	09-30-2017	10-Q
29	07-28-2017	06-30-2017	10-Q
30	05-05-2017	03-31-2017	10-Q
31	03-08-2017	12-31-2016	10-K
32	10-28-2016	09-30-2016	10-Q
33	08-05-2016	06-30-2016	10-Q
34	04-29-2016	03-31-2016	10-Q
35	02-29-2016	12-31-2015	10-K
36	10-30-2015	09-30-2015	10-Q
37	07-31-2015	06-30-2015	10-Q
38	05-01-2015	03-31-2015	10-Q
39	03-02-2015	12-31-2014	10-K
40	10-31-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

AtriCure Reports First Patient Has Been Tr...
08/27/2024 12:04:44

AtriCure, Inc. ((ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial ap...

AtriCure Receives Expanded Indication For ...
08/22/2024 12:03:32

Navigating 6 Analyst Ratings For AtriCure
07/31/2024 19:01:40

BTIG Maintains Buy on AtriCure, Lowers Pri...
07/31/2024 18:45:06

BTIG analyst Marie Thibault maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $58 to $53.

JP Morgan Maintains Overweight on AtriCure...
07/31/2024 18:32:46

JP Morgan analyst Robbie Marcus maintains AtriCure (NASDAQ:ATRC) with a Overweight and lowers the price target from $34 to $30.

Stifel Maintains Buy on AtriCure, Lowers P...
07/31/2024 15:28:43

Stifel analyst Rick Wise maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $30 to $26.

Needham Maintains Buy on AtriCure, Lowers ...
07/31/2024 12:02:07

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $40 to $34.

Piper Sandler Maintains Overweight on Atri...
07/31/2024 11:33:50

Piper Sandler analyst Matt O'Brien maintains AtriCure (NASDAQ:ATRC) with a Overweight and lowers the price target from $...

AtriCure Q2 2024 GAAP EPS $(0.17), Inline,...
07/30/2024 20:04:25

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. The company re...

AtriCure Receives National Medical Product...
07/23/2024 12:05:00

Analyst Ratings For AtriCure
07/08/2024 19:01:12

Needham Reiterates Buy on AtriCure, Mainta...
07/08/2024 17:59:53

Needham analyst Mike Matson reiterates AtriCure (NASDAQ:ATRC) with a Buy and maintains $40 price target.

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 16:31:11

Watching AtriCure; Traders Circulating Unc...
06/18/2024 15:11:37

Canaccord Genuity Maintains Buy on AtriCur...
05/02/2024 19:10:40

Canaccord Genuity analyst William Plovanic maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $57 ...

JP Morgan Maintains Overweight on AtriCure...
05/02/2024 16:09:31

JP Morgan analyst Robbie Marcus maintains AtriCure (NASDAQ:ATRC) with a Overweight and lowers the price target from $42 to $34.

Cracking The Code: Understanding Analyst R...
05/02/2024 12:01:21

Needham Maintains Buy on AtriCure, Lowers ...
05/02/2024 09:45:28

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $46 to $40.

ArtiCure Sees FY24 Adj. EPS $(0.82)-$(0.74...
05/01/2024 20:38:29

AtriCure Q1 2024 Adj EPS $(0.25) Misses $(...
05/01/2024 20:21:50

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by...